An AI search over excipient blends kept mRNA vaccines potent for months at high heat, a step toward freeing clinical…
Red Queen Bio has raised $36M to build AI-designed antibody drugs fast enough to outrun whatever frontier models might enable.
HITS, the KAIST spinout, has raised $13.4M to put AI agents that search literature, analyze data and test hypotheses into…
The Australian biotech will use Amazon's cloud and AI tools across discovery and clinical development, from target hunting to regulatory…
A Boston company working on technology licensed from Mass General Brigham wants AI to connect evidence across entire preclinical safety…
A lab led by attention-mechanism pioneer Kyunghyun Cho has a $500M commitment to build one foundation model spanning biology, clinical…
DeepTek is cutting the price of its chest X-ray AI to about a third for public and non-profit providers across…
The Shanghai biotech won clearance for NTS231, a compound aimed at a protein that helps tumors survive treatment.